ask="N/A"
ask_size="N/A"
average_daily_volume="39303"
bid="17.50"
bid_size="100"
book_value="5.83"
change="-1.07"
change_from_200_day_moving_average="-1.34"
change_from_50_day_moving_average="-2.16"
change_from_52_week_high="-8.46"
change_From_52_week_low="7.88"
change_in_percent="-5.64%"
close="17.90"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-13.50"
ebitda="-25.94M"
eps_estimate_current_year="N/A"
eps_estimate_next_quarter="-0.61"
eps_estimate_next_year="-2.23"
ex_dividend_date="N/A"
float_shares="6895000"
high="19.01"
high_52_weeks="26.36"
last_trade_date="2/7/2017"
last_trade_price="17.90"
last_trade_size="1209"
last_trade_time="4:00pm"
low="17.57"
low_52_weeks="10.02"
market_capitalization="299.18M"
moving_average_200_day="19.24"
moving_average_50_day="20.06"
name="Protagonist Therapeutics
Inc."
notes="N/A"
one_year_target_price="31.00"
open="18.37"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-6.98%"
percent_change_from_50_day_moving_average="-10.78%"
percent_change_from_52_week_high="-32.09%"
percent_change_from_52_week_low="+78.64%"
previous_close="18.97"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.25"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="16714000"
short_ratio="4.14"
stock_exchange="NGM"
symbol="PTGX"
volume="35477"
weeks_range_52="10.02 - 26.36"
